RecruitingNCT06384924

Raman Spectroscopy and Skin Cancer

Pilot Study of Raman Spectroscopic Imaging for Skin Cancer


Sponsor

Renee Farrell

Enrollment

20 participants

Start Date

Feb 13, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to find out if Raman Spectroscopy, a type of imaging, can be used to determine the size of skin cancer tumors. The main question it aims to answer is: -Can Raman Spectroscopy help figure out how far a tumor spreads? This study will take measurements using laser light from an experimental, handheld probe by lightly touching the skin.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Histologically confirmed skin cancer (either basal cell carcinoma or squamous cell carcinoma)
  • Participants must plan to receive brachytherapy treatment for the skin cancer at the study site.
  • Ability to provide consent to the study.

Exclusion Criteria4

  • Patient belongs to a vulnerable population (Minors (under 18 years old), Adults unable to consent, prisoners).
  • Lesions on the eyelid or in close proximity to the eye
  • Pregnant women, or women of childbearing age who refuse pregnancy testing.
  • Patient has pacemaker.

Interventions

DEVICERaman Spectroscopy handheld probe (EmVision, FL, USA)

The probe is approximately the size of a pen or pencil. The handheld probe is connected to the laser source using a cable. The probe is placed in light contact with the skin. The features of the laser light after it bounces off the skin is collected. This measurement can allow us to see tissue characteristics. This is a single session that will take approximately 15 minutes.

DEVICERaman Spectroscopy laser source (Hubner Photonics Inc, CA, USA)

This light source will create the laser light that will pass through the cable and through the handheld probe onto the skin.


Locations(1)

Stony Brook Hospital

Stony Brook, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06384924


Related Trials